Skip to main content

Advertisement

Log in

Isoniazid-triggered pure red cell aplasia in systemic lupus erythematosus complicated with myasthenia gravis

  • Case Report
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

A 47-year-old woman who had been treated for systemic lupus erythematosus (SLE) with myasthenia gravis (MG) was admitted to our hospital with acute onset of severe anemia after administration of isoniazid. Pure red cell aplasia (PRCA) was confirmed by elevated serum iron levels, reticulocytopenia and bone marrow aspiration showing a remarkable reduction of erythroblasts. Finally, cyclosporine A successfully improved PRCA. Although both SLE and MG have the potential complication of PRCA, we report here a case of isoniazid-triggered PRCA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Abbreviations

CyA:

Cyclosporine A

SLE:

Systemic lupus erythematosus

MG:

Myasthenia gravis

PRCA:

Pure red cell aplasia

References

  1. Lim LC (2005) Acquired red cell aplasia in association with the use of recombinant erythropoietin in chronic renal failure. Hematology. 10:255–259

    Article  CAS  PubMed  Google Scholar 

  2. Liang TB, Li DL, Yu J, Bai XL, Liang L, Xu SG et al (2007) Pure red cell aplasia due to parvovirus B19 infection after liver transplantation: a case report and review of the literature. World J Gastroenterol 13:2007–2010

    PubMed  Google Scholar 

  3. Atzeni F, Sarzi-Puttini P, Capsoni F, Vulpio L, Carrabba M (2003) Successful treatment of pure red cell aplasia in systemic lupus erythematosus with cyclosporin A. Clin Exp Rheumatol 21:759–762

    CAS  PubMed  Google Scholar 

  4. Casadevall N, Cournoyer D, Marsh J, Messner H, Pallister C, Parker-Williams J et al (2004) Recommendations on haematological criteria for the diagnosis of epoetin-induced pure red cell aplasia. Eur J Haematol 73:389–396

    Article  PubMed  Google Scholar 

  5. Loulergue P, Mir O, Dhote R (2007) Pure red blood cell aplasia and isoniazid use. Emerg Infect Dis 13:1427–1428

    PubMed  Google Scholar 

  6. Lewis CR, Manoharan A (1987) Pure red cell hypoplasia secondary to isoniazid. Postgrad Med J 63:309–310

    Article  CAS  PubMed  Google Scholar 

  7. Erslev AJ, Soltan A (1996) Pure red cell aplasia: a review. Blood Rev 10:20–28

    Article  CAS  PubMed  Google Scholar 

  8. Dessypris EN, Redline S, Harris JW, Krantz SB (1985) Diphenylhydantoin-induced pure red cell aplasia. Blood. 65:789–794

    CAS  PubMed  Google Scholar 

  9. Mizobuchi S, Yamashiro T, Nonami Y, Yamamoto A, Kume M, Nakaya H et al (1998) Pure red cell aplasia and myasthenia gravis with thymoma: a case report and review of the literature. Jpn J Clin Oncol 28:696–701

    Article  CAS  PubMed  Google Scholar 

  10. Habib GS, Saliba WR, Froom P (2002) Pure red cell aplasia and lupus. Semin Arthritis Rheum 31:279–283

    Article  PubMed  Google Scholar 

  11. Arcasoy MO, Chao NJ (2005) T-cell-mediated pure red-cell aplasia in systemic lupus erythematosus: response to cyclosporin A and mycophenolate mofetil. Am J Hematol 78:161–163

    Article  PubMed  Google Scholar 

  12. Sawada K, Hirokawa M, Fujishima N, Teramura M, Bessho M, Dan K et al (2007) Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group. Haematologica. 92:1021–1028

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hideki Nakamura.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakamura, H., Okada, A., Kawakami, A. et al. Isoniazid-triggered pure red cell aplasia in systemic lupus erythematosus complicated with myasthenia gravis. Rheumatol Int 30, 1643–1645 (2010). https://doi.org/10.1007/s00296-009-1113-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-009-1113-2

Keywords

Navigation